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Abstract
Background: The Australian Home Medicines Review (HMR) program consists of a pharmacist reviewing a patient’s
medicines at his or her home and reporting findings to the patient’s general practitioner (GP) to assist optimisation
of medicine management. Previous research has shown that the complex HMR program rules impede access to the
HMR program by Aboriginal and Torres Strait Islander clients.
This study explores the attitudes and perceptions of health professional employees working within Aboriginal
Health Services (AHSs) towards the HMR program. The goal was to identify how the HMR program might better
address the needs of Aboriginal and Torres Strait Islander people.
Methods: Thirty-one semi-structured interviews were conducted with health professionals at 11 diverse AHSs.
Fourteen Aboriginal Health Workers (AHWs), five nurses, one manager and 11 GPs were interviewed. Interviews
were recorded, de-identified and transcribed verbatim. Transcripts were coded and analysed for themes that
recurred throughout the interviews.
Results: This study identified a number of barriers to provision of HMRs specific to Aboriginal and Torres Strait
Islander clients. These included paternalistic attitudes of health professionals to clients, heightened protection of the
GP-client relationship, lack of AHS-pharmacist relationships, need for more culturally responsive pharmacists and the
lack of recognition of the AHS’s role in implementation of culturally effective HMRs.
Changes to the HMR model, which make it more effective and culturally appropriate for Aboriginal and Torres Strait
Islander people, were recommended. Improved relationships between GPs and pharmacists, between pharmacists
and AHSs, and between pharmacists and Aboriginal and Torres Strait Islander clients were identified as key to
increasing HMRs for Aboriginal and Torres Strait Islander people.
Conclusions: Aboriginal Health Services are well-placed to be the promoters, organisers, facilitators and
implementers of health programs, such as HMR, for Aboriginal and Torres Strait Islander clients.
Embedding a pharmacist within an AHS addresses many of the barriers to HMRs. It ensures pharmacists are
culturally mentored and that they build strong relationships with health professionals and clients.
The HMR program rules need to be changed significantly if medication review is to be an effective tool for
improving medication safety and adherence for Aboriginal and Torres Strait Islander people.
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Background
The Australian Home Medicines Review (HMR) has been
found to be an effective tool for improving medication
safety, and reducing adverse events and unnecessary
hospital admissions [1–3]. It consists of a pharmacist
reviewing a patient’s medicines and reporting findings to
the patient’s general practitioner (GP) to assist optimisa-
tion of medicine management. It is a ‘free to patient’, Aus-
tralian Government managed program. An HMR referral
is initiated by the patient’s GP and then an HMR-
accredited pharmacist is organised to visit and interview
the patient in his or her home. The pharmacist sends a re-
port of findings to the GP, who then discusses recommen-
dations and makes any appropriate medication changes in
collaboration with the patient [4].
To claim funding from the Australian Government
for an HMR the GP and pharmacist must adhere to
program rules [4]. In the 2008 evaluation report [5] the
complexity of business rules and the number of steps
involved in the HMR process were identified as barriers
to initiation of HMRs. The program rules stipulate the
HMR referral can only be written by a GP. The GP
must obtain the patient’s consent, a GP can only claim
funding through the Medicare Benefits Scheme after a
second visit from the patient to discuss the pharmacist’s
HMR report and formulate the medication manage-
ment plan, and the GP can only bill one out of the two
consultations relating to the HMR. The suggested
HMR referral form requires the GP to specify detailed
patient information, and medical and medication his-
tory. The GPs often confuse the suggested indications
on referral forms, such as taking five or more regular
medications, with the specific rules for HMR program
eligibility [5]. Rules state that a patient may only receive
an HMR every 24 months or if a GP deems an HMR is
specifically necessary due to significant changes to the
patient’s condition or medication regimen. The latter
part of this rule is rarely applied, for most GPs and
pharmacists are concerned they will not receive pay-
ment if they step outside the specified 24 months.
Thus, some eligible patients are not being referred for
HMRs. The 24-month rule appears to have been ap-
plied due to budgetary restrictions of the program
rather than as a result of any data that determine that
this is an appropriate timeline for maximising medica-
tion management [6].
The HMR program rules and claim lodgement pro-
cesses are also restrictive for pharmacists, as described
below and as lamented by pharmacists in concurrent
research [7]. The program’s rules have actually increased
rather than decreased under the recent Fifth Government-
Community pharmacy agreement [4]. The HMR payments
can only by claimed by pharmacists if the HMR is con-
ducted by an HMR-accredited pharmacist, if the patient is
living in a community setting, if the claim is submitted
within 30 days of conducting the patient interview, and if
the HMR-accredited pharmacist has conducted fewer than
20 HMRs within the month. Rules state that an HMR
interview must occur in the patient’s home unless prior ap-
proval has been obtained from the Pharmacy Guild of
Australia, which manages the HMR program. This prior
approval has to be sought by the pharmacist on a case-to-
case basis, giving full patient details to the Pharmacy Guild
of Australia, at least 10 days prior to the proposed inter-
view date [4].
The evaluation of the HMR program in 2008 [5]
included perspectives of GPs and pharmacists on the
HMR program. Those interviewed described how while
HMRs were a “good idea”, the program was not work-
ing well. Dominant themes in the evaluation report
included the complexity of business rules, time delays
between HMR initiation and completion, and commu-
nication difficulties between GP and pharmacist. It re-
ported that whilst the GPs who had experienced HMRs
were very positive, the others were mostly ambivalent.
Many valued HMRs as a lower priority than health as-
sessments [5].
The 2008 HMR evaluation report, commissioned by
the Department of Health [5], also identified that Abori-
ginal and Torres Strait Islander people, despite their
high burden of chronic disease, were the most likely of
all Australians to miss out on HMRs and that the
current HMR model was not appropriate for Aboriginal
and Torres Strait Islander people [5]. A recent study [8]
has explored the views of Aboriginal and Torres Strait
Islander patients about the HMR program. The Aborigi-
nal and Torres Strait Islander patients in that study felt
an HMR would assist them to better understand their
medicines and empower them to seek information about
medicines, would improve relationships with health
professionals and would increase the likelihood of medi-
cation adherence. These Aboriginal and Torres Strait Is-
lander patients concluded, however, that current HMR
rules impeded rather than facilitated HMRs for Aborigi-
nal and Torres Strait islander people [8]. Barriers to
HMR delivery were the program guidelines that stated
an HMR should be delivered in the patient’s home, the
referral process that required patients to organise the
HMR interviews with the pharmacists and the lack of re-
imbursement for Aboriginal Health Worker (AHW) in-
volvement in HMR processes [8].
This study explores the attitudes and perceptions of
health professional employees working within Aborigi-
nal Health Services (AHSs) towards the HMR pro-
gram. The goal was to identify how the HMR
program might better address the needs of Aboriginal
and Torres Strait Islander patients. No previous HMR
studies have analysed the views of health professionals
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working with Aboriginal and Torres Strait Islander
patients.
Method
This qualitative descriptive study explored AHS em-
ployees’ perceptions of the HMR model. The design was
appropriate for this study because it facilitated the gather-
ing of rich, contextual data related to service delivery in
AHSs. Participants included GPs, nurses, AHWs and an
AHS manager.
Eleven AHSs in Queensland, Northern Territory (NT),
South Australia (SA), New South Wales (NSW) and
Victoria participated. The sites were selected for diversity
and included urban (n = 2), regional (n = 3), rural (n = 2)
and remote (n = 4) settings. They varied in governance
and size. Some AHSs were initiating HMRs for their
patients whilst others were not. The AHSs (n = 5) which
were known to be proactively conducting HMRs were
approached so that the views of health professionals who
had had experience with HMRs could be explored. The
other sites were chosen to given geographical diversity. All
sites approached agreed to participate.
Each AHS was given verbal, and then written informa-
tion about the project, and the management and boards
were asked to approve participation in the study. Each
board gave written consent. Written consents were sub-
mitted to state Aboriginal ethics committees. A feedback
report was sent to each AHS after research was con-
ducted. All individual participants were given written and
verbal information about the study, and written consent
was obtained from each participant.
An interview guide was designed with key open-ended
questions to encourage a natural exploratory conversation
with the interviewee. The interviewer used the questions
to prompt the sharing of the participant’s experiences and
ideas. All interviews were face to face and conducted by
the same researcher. Questions were modified to ensure
all content raised in early interviews was explored
subsequently.
Thirty-one semi-structured interviews were conducted
at 11 AHSs. The numbers of each profession participating
were influenced by staff availability and willingness to
participate at each AHS. Fourteen AHWs, five nurses, one
manager and 11 GPs were interviewed. See Table 1 for
interview guide.
Of the 11 participating AHSs in this study, three were
conducting HMRs regularly, four occasionally and four
not at all. Only at the three AHSs, where there were
contracted pharmacists, were patients being referred regu-
larly for HMRs. One of these AHSs had a salaried
pharmacist employed by the AHS for a range of clinical
pharmacy roles, including HMRs. The other two had each
contracted an HMR-accredited pharmacist to conduct
HMRs, with one using a chronic care nurse and the other
an AHW to co-ordinate the program. Although only three
GPs were referring patients for regular HMRs, all inter-
viewed GPs were aware of the HMR program although
some lacked understanding of the HMR referral processes.
The majority of nurses and AHWs interviewed were un-
aware of the HMR program.
Interviews were recorded, de-identified and tran-
scribed verbatim. Transcripts were coded and analysed
Table 1 Semi-structured Interview Guide
1. Explore attitudes to HMR program How do you feel about the HMR program?
How likely are you to order a HMR for a patient?
How often do you order HMRs? What determines this?
2. Explore understanding of HMR processes Who do you order HMRs for? Why?
How do you find the HMR process?
Do you have assistance from other staff members in organizing HMRs? If so, how?
3. Identify reasons for ordering HMRs (benefits) How useful have you found HMRs? or How useful do you think an HMR could be?
What is the most useful aspect of an HMR?
What feedback have you had from your patients about the HMR?
How do you find the pharmacists’ reports?
4. Identify barriers to initiating HMRs Is there a reason why you don’t order more HMRs? Please explain
Would you like to order more HMRs? Please explain
What are the limiting factors in referring patients for an HMR?
Why do you think there are not many HMRs are being conducted for
Aboriginal and Torres Strait Islander patients?
5. Encourage recommendations Do you believe the current HMR model is effective/not effective? Please explain
How appropriate is the HMR model for your patients?
Are there any ways the model could be improved? If so, how?
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for themes that recurred throughout the interviews.
Analysis occurred concurrently.
Ethics approval was sought and granted from the Uni-
versity of Sydney Human Research Ethics Committee
(11504), the Aboriginal Health and Medical Research
Council (NSW), the Menzies School of Health Research
(NT, SA) and the Aboriginal Health Research & Ethics
Committee (Victoria).
Results
The study participants who had experienced an HMR
were extremely supportive of the program. The four GPs
who had never referred patients for HMRs expressed res-
ervations about the value of HMRs and concerns over the
need to burden patients with further referrals. Two of the
nurses interviewed were not supportive of HMRS. These
nurses believed that although HMRs were “good in the-
ory” Aboriginal patients were “not interested” and “there’s
no point filling them up with a huge amount of education
if they are not going to take the medicines anyway”. The
AHSs who had not previously been involved in HMRS
were very keen to understand the details of the HMR pro-
gram as they felt it would greatly assist their clients who
they believed often “don’t understand how the medicines
work, when they work, and they don’t take them at the
right times or the right way”. Most of the interviewees
expressed positive views regarding the potential benefits
of HMRs for their patients’ health.
The emergent themes, and the perceived benefits of
and barriers to the HMR program, are discussed below
and summarised in Table 2.
“Home Medicines Reviews are useful”
Three of the five nurses and all AHW interviewees de-
scribed increased medicine knowledge and empower-
ment of patients to make medicine choices as the
potential benefits of the program, stating, “HMRs were
good for understanding what they’re taking and why
they are taking medicines and the importance of medi-
cines”. They also felt HMRs would assist patients to
learn about potential dangers in storing medicines and
sharing medicines. Most of the interviewees strongly
agreed that an HMR could be useful in reducing medica-
tion “fear and worries about the unknown”.
All the AHW interviewees expressed concern about
patient confusion regarding their medicines, stating “ge-
nerics confuse the hell out of people” and “in hospital
they start swapping and changing medications. It gets
very confusing”.
The majority of the GP interviewees also felt patients
would benefit from increased medicine knowledge and
that patients would benefit from having “someone else
reinforcing information that the doctor has given”. The
majority of GPs believed that HMRs could assist their
patients to feel more confident about taking their medi-
cines and felt HMRs would “elevate the medications up
the priority list”. The majority of participants believed
that most patients would be “really keen” to have HMRs,
although there may be a few patients who “see it as a
failure to have someone come and talk to them”.
The GP interviewees who had referred patients for
HMRs praised how HMRs had identified potential drug
interactions and had identified “an astounding number
of discrepancies between what we had on our system
and what clients were taking”. Also, these GPs valued
how HMRs assisted their therapeutic decision-making,
assisted them to sometimes cease medications and in-
creased their own understanding of medicines. The GPs
liked the HMR reports as the “pharmacists fed back lots
of information about whether there are lots of other
medications from other places and whether there is con-
fusion and that sort of thing”.
Other benefits of HMRS stated by the GP inter-
viewees included improved understanding of whether
their patients had high falls risk, were medication ad-
herent, and were sharing or hoarding medicines. A few
GP participants also commented that they felt HMRs
would assist with building relationships between pa-
tients and pharmacists.
“I just don’t get around to ordering HMRs”
Despite most of the participating AHS GPs agreeing that
HMRs would be very useful for their complex patients
and for supporting their therapeutic decisions, only
three of the 11 GPs interviewed were actually referring
their patients for HMRs regularly.
The most common reasons for the GPs not “getting
around” to ordering HMRs for their patients included lack
of time, protection of their client-clinician relationships,
lack of relationships with pharmacists and cultural in-
appropriateness of the HMR program. Some other reasons
included complex HMR processes, not prioritising medi-
cines in their patient discussions, GP ownership of their
role in advising on medicines, and perceived lack of
evidence for the value of HMRs. Two of the GPs reflected
paternalistic attitudes, commenting, “they [their Aborigi-
nal patients] are not particularly interested in having an
intervention like a HMR” and “In terms of education,
which I know is one of the really important parts, I’m not
sure. I’m not convinced that those people think it is a high
priority and that we have any way of educating these
people about their medications”. Two GPs commented
that reviewing patients’ medicines was part of their
practice, stating, “if a patient had concerns about their
medicines they would come and talk to us about it. The
clinic has primary responsibility for those things” and “I
do a lot of it [medication review] myself actually”.
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Table 2 Most common perceived benefits and barriers of the HMR program
Benefits of HMRs AHS staff comments
Increased patient understanding and
confidence
The HMR interview is a good opportunity to iron out some confusion about medicines. (AHW)
The clients need to know the importance of taking medicines and why they are taking them. (AHW)
It helps my patients understand their medicines a bit more. (GP)
Just having another person go over it, having a bit more time and in different words can be very useful. (GP)
There’s the empowerment they(the patient) get from a more clear understanding. (nurse)
Improve medication adherence Because the people don’t feel they’re working, they tend not to take them. (AHW)
If you explain to them (the patients) what it is, how it works and what to watch out for, then there’s some
informed decision making and they’re more likely to take them (medicines). (AHW)
It gave my patient more confidence to take his medicines, just having someone reassure him that the medicines
he was taking were appropriate. (GP)
Supporting GP practice You get to learn stuff that you wouldn’t normally know about your patient. You learn about the gap, about what you
think is going on and what is really going on, and you also learn stuff about medicines that you didn’t know. (GP)
The reports can be revelationary. You find out people are taking all sorts of things, some that you ceased months
ago. (GP)
When a locum comes, and we have lots, they just prescribe the drugs because the patient asks for them. They
don’t review them or work out if they really need them. (AHW)
Barriers to HMRs AHS staff comments
Lack of awareness None of us here know about home medicines review. (AHW)
People are not aware they can ask for, or should ask for their medicines to be reviewed. (AHW)
They (the patient) don’t know that pharmacists can do things like reviews. (AHW)
Workload Time is the main thing that has put me off (GP)
We are already inundated with administrative tasks (GP)
Aboriginal Medical Service workloads are pretty demanding. A lot of these people that qualify for an HMR also qualify
for EPC, care plans, health assessments and that kind of stuff, so that might be where they’re going first. (nurse)
One of the difficulties is having enough health workers on board to do it (participate in an HMR). Having a health worker
who is trained enough to go with the pharmacist, who is trained in quality use of medicines and who understands what
the pharmacist is talking about and take a lead in the whole process would be the ideal. (AHS manager)
Protection of the Clinician-client
relationship
They’re (patients) already getting referred to lots of different people for lots of different things. So another referral
might just feel like too much (GP)
Gaining someone’s confidence and trust and having a meaningful clinical interaction requires proper cross cultural
training and working with the community over some time.(GP)
Doctors are concerned about overloading the patient. (nurse)
Lack of Clinician/AHS pharmacist
relationship
The GPs aren’t driving it (HMR referrals) as they don’t have a relationship with a pharmacist who can do it for them (GP)
The relationship between the doctor and the pharmacist might not be established. If they had a rapport and a
referral pathway going already that would really help. (nurse)
The community pharmacists around here are very busy. I don’t think they have time to get it done (GP)
It would be important for the pharmacist to have some cross cultural training (AHW)
The chronic health nurse or AHW needs to have a direct link with the accredited pharmacist, not the pharmacy. (nurse)
Generally our clients do not have a relationship with a pharmacist (nurse)
Lack of an HMR facilitator/driver/
program manager
We need someone at the health service allocated to encouraging the home medicines review, co-ordinating it,
blocking out time for GPs to do referrals, taking on the role of doing the consent. (GP)
It needs something set in place so that it can be done regularly (GP)
We rely on a co-ordinator to organize all the logistics (GP)
There needs to be a single point of contact, health worker to patient.(AHW)
Somebody who is well known to the patient needs to ring and explain the process. (AHW)
Complex HMR model and rules It took a while to make sense of the steps (GP)
I think the criteria are a bit restrictive. (GP)
It was not clear that all pharmacists were not accredited. I was sending off referral letters and nothing happened (GP)
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All the GP interviewees commented that the biggest
barrier to writing HMR referrals was “being pushed for
time”, and half of the GPs felt that writing an HMR
referral was a barrier as it was “just another bureau-
cratic, red tape thing to do when you’re seeing patients”.
Patients at the AHSs often had complex co-morbidities,
and although most interviewees agreed that HMRs were
desirable, the GPs felt they had “to sort out the multiple
things a patient presents with, do a GP plan and a team
arrangement and a health check first. An HMR is just
another thing on a list of things that you know you need
to do”. At times some felt they were “snowed under with
the acute stuff before you even get to the chronic stuff”.
In the three AHSs where GPs were writing regular HMR
referrals they had found other staff members to assist
the process, and one commented, “It takes time to offer
and explain it [HMR] and do the referral. That is just
too onerous to fit into an appointment. So I get the
health worker to do it.”
The eight GPs who were not regularly referring patients
for HMRs made comments which reflected their wish to
protect their clinician-client relationships. “There are lots
of practitioners with lots of clinicians involved already”
and “We need to make sure we are not overburdening
them [the patients] with our efforts.” These GPs particu-
larly showed some uncertainty about referring their
patients to a pharmacist, indicating a lack of GP-
pharmacist relationships. Five GPs perceived that their
local pharmacists were too busy to do HMRs, comment-
ing, “we think that some pharmacists are too busy. I guess
we worry that the pharmacist might not be very recep-
tive.” Two GPs had had their HMR referrals ignored or
returned by pharmacies. “I was sending off referral letters
and nothing happened.”
Seven of the GPs commented that pharmacists needed
to be culturally sensitive, have some cultural training and/
or show an interest in working with Aboriginal people
before they would feel comfortable referring their
Aboriginal patients to them. Comments included, “I am
not sure how culturally aware the pharmacists are” and “If
we [the AHS] had a relationship with a particular pharma-
cist who we knew our people were comfortable with that
would really help.” The nurses also felt that the lack of a
pharmacist-client relationship was problematic, stating,
“It’s not very often that you will have a relationship
between the client and the pharmacist.” Conversely, in the
AHSs where pharmacists had been contracted, the phar-
macists were highly valued and regarded. “They [the GPs]
really like having the pharmacist here. The doctors
specially allocate time when she is here for the day. Now
that they have built up a rapport the doctors will actually
ring her up and ask her questions about medications.”
The AHWs also commented, “It would be important for
the pharmacist to have some cross-cultural training. For
them to be good at it, for it to be worthwhile, they need
proper cultural training. That would be key.” A few of the
interviewees bemoaned the lack of Aboriginal or Torres
strait Islander pharmacists. The majority of AHWs com-
mented on their clients’ lack of understanding of the phar-
macist’s role and on their lack of established relationships
with the local community pharmacists.
The GPs, nurses and AHWs all showed some misgiv-
ings about a pharmacist visiting an Aboriginal or Torres
Strait Islander person’s home. “I think sending a
pharmacist cold to a patient’s house is inappropriate,”
and “many Aboriginal people are not comfortable with
non-Aboriginal people going to their home.” Half the
GPs did, however, state a preference for the HMR inter-
view being conducted at the patient’s home whenever
possible as they cited the advantage of being “able to
see what is really happening” and that “one of the great
benefits is seeing the context at home. So it would be a
shame to lose that”. However, most felt that although
“It is better if it happens in the home. I wouldn’t want
them to not get an HMR just because the home is not
appropriate or suitable”, and some believed that it was
Table 2 Most common perceived benefits and barriers of the HMR program (Continued)
It would be better if someone else could refer. For a multidisciplinary team to work effectively everything should
not be done by the GP. (GP)
A lot of them think it is all done once the pharmacist has left the house. (AHW)
The health service should promote it (HMR) and align it with other programs or something they do already.(nurse)
We don’t organize home medicine reviews for all sorts of reasons – around privacy, judgment, people not being
home, lots of people being transient or homeless, lots of people in 1 household and people not wanting strangers
in their home. (nurse)
We need a flexible mixed model where some people can come here on an appointment, or we can go there if it
suits today or where a pharmacist can just add on to an existing program. (AHW)
Lack of Financial Reimbursement The AMS should be able to claim something for organizing an HMR. (AHS manager)
It should be the AMS who is doing all the organizing who gets a cut, not the pharmacy. (nurse)
AHWs are very important to the process. They need to be reimbursed for their time, just like the pharmacists and
GPs. (GP)
Swain and Barclay BMC Health Services Research  (2015) 15:366 Page 6 of 12
preferable to “have something in the clinic where
they’re used to coming”. A couple of interviewees also
commented that having a pharmacist at the clinic
would assist in establishing relationships among GPs,
pharmacists and AHWs and would allow valuable case
conferencing and discussion about patients.
Despite most of the GPs at first stating that HMRs
could be beneficial in assisting their patients to manage
their medicines, later in their interviews, half the GPS
from the AHSs where HMRs were not occurring,
showed some scepticism about the value of HMRs.
Two of the 11 GPs perceived that “if patients had con-
cerns about their medicines they would come and talk
to us (GPs) about it”. These GPs appeared to doubt the
need for HMRs as they felt they adequately dealt with
medication issues themselves, saying, “I do a lot of it
[medication education] myself actually” and “I believe it
is my role to talk to patients about their medicines.”
Three GPs also expressed concern that their patients
“might not see the value in it” and stated, “the doctors
spend a lot of time dealing with medicines. So it might
be seen as doubling up.” The majority of GPs who were
not ordering HMRs felt that currently “the process isn’t
in place for it to happen”.
The AHWs perceived that their lack of awareness and
their clients’ lack of awareness of the HMR program
contributed to the low uptake of HMRs by their commu-
nities. Some also commented on the lack of continuity of
GPs and the number of health checks already being
conducted as barriers to implementing another program,
such as HMR, in their health services.
“Need someone to be the main organiser”
All the AHS health professionals interviewed agreed
that for HMRs to become a regular occurrence at their
AHSs it required “having someone at the health service
allocated to encouraging the HMR, co-ordinating it,
blocking out time for GPs to do the referral, taking on
the role of doing the consent”. They all agreed that this
role should be done by a senior health worker or a nurse
who really understands the process. Each of the three AHSs
where HMRs were being done had a “co-ordinator to or-
ganise all the logistics”. One AHS used the chronic care co-
ordinator nurse, another an AHW dedicated to Quality Use
of Medicines and the third a salaried pharmacist to organise
their HMRs.
Explaining the process to the patient and brokering
trust in the process was seen as an important in the
success of the program with Aboriginal and Torres Strait
Islander patients. The GPs explained, “Someone who is
well known to the patient, such as a health worker,
needs to ring and explain the process,” and “I think if
the health worker is the first port of call and clearly
explains everything, then I think people will take it up.”
Across the health professional groups there was dis-
cussion regarding how best to manage the extra work
load that HMRs would create. Most agreed that there
should be health workers specifically employed as
chronic disease health workers or even specifically as
medication specialists, and part of their role should be
facilitating the HMR process. All agreed,”the AHS
should be able to claim something for their [the
organiser’s] time” and that “it should be the AHS who is
doing all the organising who gets a cut, not the
pharmacy”.
Most GPs agreed an AHW should accompany a
pharmacist to a client interview to broker cultural trust
because “it provides an opportunity to up-skill the health
worker”. Most commented that the health worker or the
AHS should receive financial reimbursement for the
health worker’s time, in alignment with the fees received
from the Government by the GP and the pharmacist.
Many interviewees felt the organising health workers
should also be the ones attending the interviews.
“It would be better if someone else could refer”
A few of the GPs showed a lack of confidence and
knowledge about who was eligible for an HMR, about
how to write a referral, and about the HMR process it-
self, as indicated by their comments, “so you don’t have
to wait until they are on 5th medication to order an
HMR” and “It takes a while to make sense of the steps”.
All the GPs, nurses and AHWs agreed that “it is not
practical for the patient to have to take the referral to
the pharmacy”. Most of the GPs indicated that as they
were time-poor, they would be happy for a health
worker or nurse to organise the HMR and even write
the referral, or alternatively “we could do the referral
retrospectively”. The AHWs iterated their willingness
to initiate referrals: “we know the patients best. So it
would make more sense if we organised the referral.”
The nurses and AHWs believed that it was crucial
that the AHS select and refer to a specific pharmacist
known to the AHS, with whom they had a relationship
and who had been assessed by the health service for
their cultural sensitivity. The GPs also expressed the
need to establish rapport with a trusted and culturally
appropriate pharmacist before they would refer their
patients.
“The model needs to be changed”
In addition to changing referral pathways, having the
AHS organise the HMR, and having an AHW attend the
HMR interview, GPs also suggested other changes to the
HMR model. These included the pharmacists providing
patients with a brief follow-up report that also prompted
the patient to make an appointment with the GP to dis-
cuss the report, as “it is a very important step when the
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patient sits down with the GP and makes the changes
that are needed”. Many lamented that often HMR pa-
tients did not revisit the clinic to discuss a revised medi-
cation plan with the GPs.
Half the study participants mentioned that HMRs
should be incorporated into the Aboriginal health as-
sessment process, or be part of the existing GP man-
agement plan. A number of health workers also stated
that the HMR program would work best if it was a
“flexible model where you can work in with existing
programmes rather than trying to develop a whole
other system of doing things”. The AHWs suggested
pharmacists should join in existing groups, run by the
AHS, such as cardiac rehabilitation, cooking or diabetes
groups or “run alongside a chronic disease clinic that’s
happening on the day”. Most of the AHWs mentioned
that group meetings would be favoured by many cli-
ents, and so group HMRs should be an option.
All interviewers agreed that for the HMR program to
work within their AHSs it needed to be simplified. At
present there are “way too many steps”. It also needed a
systematised approach to ensure HMR referrals were
written, interviews organised, and patients followed up.
“It needs something set in place so that it can be done
regularly.” The HMR system required a “driver” who
was not too overburdened with other duties, preferably
an AHW dedicated to chronic disease and medicines.
All the AHWs interviewed stated that advising patients
about medicines was a key part of their role and that
they would like more training in this area.
The AHWs suggested that AHSs need to promote
the HMR program and inform their clients of the
steps involved, through pamphlets and posters in the
AHSs.
The GPs and AHWs suggested changing the name of
the HMR program. “The title is not good as some
patients don’t like that home bit. Some don’t like
strangers coming to their home. It needs an Aboriginal
title or at least a bit more of a friendly title.”
Figure 1 summarises the recommendations for a re-
vised, more culturally appropriate HMR model. It is
hoped that the findings and recommendations from
this study will inform the Sixth Community Pharmacy
agreement on HMR program rules for Aboriginal and
Torres Strait Islander people.
Discussion
Previous research has shown that consumers identified
improved medicine information, feeling cared for, and
increased confidence to discuss medicines with their
GPs, as potential benefits of an HMR [8, 9]. In this
study, the perspectives of the nurses and GPs who had
experienced HMRs, and the perspectives of all the
AHWs, strongly supported the findings from research
with consumers, as they, too, identified that increased
medicine knowledge and empowering consumers to
make medicine choices were the major HMR benefits.
Although the majority of GP participants, especially
those who had experienced HMRs, agreed that HMRs
could assist their understanding of their patients’ medi-
cine practices and provide clinical support, very few
HMRs were being ordered. The GPs were only referring
their patients for HMRs in three out of the 11 AHSs in
this study.
The 2008 Campbell report identified that GPs need
assistance with the structure related to HMRs and that
an HMR is very dependent on the relationship between
GP and pharmacist [5]. This study reinforced this need
for structure and relationship, with HMRs only occur-
ring in AHSs where structure had already been estab-
lished, with an AHS staff member “driving” the process
and where a pharmacist-AHS relationship had been
established. This study also reinforced the Campbell re-
port findings that an HMR was not seen as being high
on the list of priorities for GPs, due to competing de-
mand for GP time; as a result the HMR program
existed in isolation rather than in parallel with other
Medicare items [6]. The participants in this study reit-
erated that the HMR program workload needed to be
shared and a team approach adopted, especially in areas
where there were medical workforce shortages.
This study confirmed a number of the barriers to
provision of HMR services identified in previous
studies by both consumers and stakeholders. These in-
cluded complexity of program rules, concerns regarding
home visits, lack of information about the program, GP
workload and GP fears of pharmacists encroaching on
their professional space [5, 7–9]. It also identified a
number of barriers specific to Aboriginal and Torres
Strait Islander clients. These included paternalistic atti-
tudes of health professionals to clients, heightened
protection of the GP-client relationship, lack of AHS-
pharmacist relationships, need for more culturally
responsive pharmacists and the lack of recognition of
the AHS’s role in implementation of culturally effective
HMRs.
One quarter (n = 4) of the non-Indigenous health pro-
fessionals (n = 16) interviewed, demonstrated paternal-
istic or racist attitudes to their clients, claiming that
their clients were uninterested or incapable of learning
more about their medicines and thus not suitable for
HMRs. This directly contradicts research conducted
with the Aboriginal and Torres Strait Islander patients
and the AHWs at the same AHSs. The majority of pa-
tients at these AHSs were extremely interested in learn-
ing more about their medicines and very supportive of
having HMRs [8, 10]. The AHWs strongly believed
their clients would benefit from HMRS as long as the
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Fig. 1 Suggested model for medication review for Aboriginal and Torres Strait Islander people
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HMRs were conducted in a culturally appropriate man-
ner. The small sample of non-Indigenous health profes-
sionals interviewed does not allow for extrapolation
across the AHS workforce but does support previous
work which suggests that GPs and non-Aboriginal staff
at AHSs would benefit from cultural mentoring [11].
These attitudes require further investigation to assess
whether some health professionals at AHSs may require
screening or further cultural training.
The majority of the GPs interviewed in this study were
very protective of their client-clinician relationships, with
much of the GP concern related to not overloading the
patient with information and too many appointments.
Further research is needed to ascertain whether this
concern about “overloading” the patient is culturally influ-
enced. There was also considerable concern from the
AHS GP and nurse interviewees that pharmacists may be
culturally insensitive and thus, by association, may damage
patient trust. Only at the AHSs (n = 3) where a pharmacist
was contracted or embedded was there a real understand-
ing of the clinical role of the pharmacist. The lack of
relationships of the AHS staff, including the GPs, with any
pharmacists, including their local community pharmacists,
appeared to be a major barrier to the initiation of HMRs.
The lack of relationships with AHSs was also noted by
pharmacists themselves in recent research [7]. This sup-
ported previous research which suggested that lack of
face-to-face interactions and established relationships be-
tween GPs and community pharmacists may be significant
barriers to collaboration [12]. It appears that significant
work is needed to build bridges between pharmacists and
GPs, and between pharmacists and AHSs, and to provide
cultural training for pharmacists. Pharmacy organisations
are currently lobbying the Commonwealth Government
to fund salaried pharmacists within AHSs to enable
culturally trained pharmacists to develop relationships
with AHSs and their clients [13].
All the interviewees agreed that for many of their
Aboriginal and Torres Strait Islander clients to feel
confident in engaging with HMRs, the HMRs needed to
be organised and facilitated by AHS employees. This
was also the finding of recent research which examined
the views of Aboriginal and Torres Strait islander pa-
tients who also identified the need for the option of
having an AHW attend the HMR interview [8]. Despite
the acknowledgment by the Australian Government that
pharmacies organising HMRs are entitled to a fee [4],
there has been no acknowledgment of reimbursement
for AHSs, which fulfil an even larger role in HMR facili-
tation for Aboriginal and Torres Strait Islander people.
The AHWs in this study identified the need for AHSs to
have AHWs who specialise in assisting patients with
medication management and who could facilitate the
HMR process. Most AHWs were keen to undertake
further training about medications as they saw assisting
patients with their medications as an important part of
their role. In the AHSs (n = 3) which were initiating
HMRs, a number of the AHWs were identifying patients
and organising HMR referrals. All interviewees, including
the GPs, were keen for nurses and AHWs to be allowed to
write HMR referrals, seeing it as unnecessary for GPs to
be involved in this process. Another study has requested
that community nurses be allowed to refer patients for
HMR [14]. A one-off HMR every 12–24 months was not
seen as ideal. For complex patients with multiple medica-
tions, regular interactions with pharmacists to reinforce
medication messages is needed.
Despite the Australian Government’s commitment to
improving the health and wellbeing of Aboriginal and
Torres Strait Islander Australians and to closing the health
inequality gap [15], Aboriginal and Torres Strait Islander
health status remains poor, and burdens of chronic dis-
eases, such as respiratory disease, diabetes and cardiovas-
cular disease, remain very high [16]. A number of studies
have identified that medication management is an import-
ant issue which urgently needs to be addressed if the
progression of chronic disease and all the associated com-
plications are to be slowed [10, 17–19]. Although the
Australian Government has implemented a number of
programs to assist Aboriginal patients with financial
barriers to accessing medicines, recent changes to the
HMR program rules have increased the barriers to acces-
sing HMRs, and thus exacerbated issues of medication
management, efficacy, safety and adherence. Changes to
the HMR program have purposively been implemented to
curtail the number of HMRS being conducted to reduce
expenditure in a program with a capped budget [4]. These
program changes have disproportionately affected those
most in need, i.e. Australia’s sickest people, the elderly,
rural people and Aboriginal people [6].
The VALMER study was an economic evaluation of
the HMR program by the University of Tasmania,
which analysed 180 HMRS across Australia. It con-
cluded that HMRs could significantly decrease health-
care utilisation costs as well as improve patients’
quality of life [20]. Overall healthcare savings and
benefits should be taken into consideration when
funding for the HMR program is assessed and guide-
lines rewritten in the Sixth Pharmacy Community
Agreement 2015. New health models, such as shared
medical appointments, which use group consultations
to improve patient health, should be used to inform
new HMR modelling and maximise outcomes from
expenditure [21, 22]. Recommendations from this
study and from the 2008 Campbell evaluation report
should be considered in developing an HMR model which
is effective and culturally appropriate for Aboriginal and
Torres Strait Islander people.
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Study limitations
The sample of AHS health professionals who were inter-
viewed was small, and the representation of each profes-
sion even smaller, and therefore findings cannot be
extrapolated to all AHS employees or across professions.
The views of health professionals who work with Aborigi-
nal and Torres Strait islander people in settings other than
AHSs were not sought. However, internal validity and reli-
ability was achieved by asking questions about the same
issues numerous times, in appropriate, non-leading ways,
with this method yielding similar findings in a range of
different settings. Many of the findings in this study
endorsed results from research undertaken with Aborigi-
nal and Torres Strait Islander patients [8] and pharmacists
working with AHSs [7].
Conclusion
Increasing HMRs for Aboriginal and Torres Strait Islander
people has the potential to increase patients’ medication
knowledge and medication adherence and thus improve
chronic disease management [8]. The HMRs teach health
service staff about their patients and about medications,
and provide GPs with invaluable information which assists
them to more optimally manage their patients’ medica-
tions and health.
Currently, very few HMRs are being conducted with
Aboriginal and Torres Strait Islander people, largely due
to lack of awareness, the paternalistic attitudes of some
health professionals and the logistics of navigating the
HMR program rules. The GPs at most AHSs are writing
very few HMR referrals due to the complexities of pa-
tients’ needs, shortage of time, and lack of trust in phar-
macists’ ability to appropriately manage their patients.
The AHSs, as the trusted brokers of Aboriginal social,
emotional and physical wellbeing and with their under-
standing of community history and relationships, are
well-placed to be the promoters, organisers, facilitators
and implementers of health programs, such as HMRs,
for Aboriginal and Torres Strait Islander clients. Within
AHSs, staff juggle numerous programs and funding
streams, and so the HMR program needs to be simpli-
fied and integrated within existing programs, and have
“champions” in each health service to promote and
drive the program.
The name of the HMR program and the myriad of
HMR rules need to be changed and simplified. Referral,
feedback and follow-up processes in particular need to
be revised. Much work is needed to improve GP-
pharmacist professional relationships and pharmacist-
AHS relationships. The GPs, nurses and AHWs who
have no previous experience with HMRs have little or
no understanding of the role of the pharmacist. A big-
picture approach is needed in the restructuring of the
HMR program, using evidence-based decision-making
and Aboriginal community consultation.
Embedding pharmacists within AHSs, even in a part-
time capacity, is a solution which addresses many of the
barriers to HMRs which have been identified in this
study. It enables the HMR program to be integrated with
other services and assists GPs to offer optimal medica-
tion therapy. It ensures pharmacists are culturally men-
tored and that they build strong relationships with
health professionals and patients. It encourages regular
“coaching” of patients to assist medication adherence. If
the Australian Government is to honour its commitment
to improve Aboriginal and Torres Strait Islander health
it needs to fund an uncapped medication review pro-
gram and embed salaried pharmacists within AHSs.
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